Lipella Pharmaceuticals (LIPO) Expected to Announce Earnings on Tuesday

Lipella Pharmaceuticals (NASDAQ:LIPO) is projected to post its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Lipella Pharmaceuticals to post earnings of ($2.43) per share for the quarter.

Lipella Pharmaceuticals Stock Performance

Shares of LIPO opened at $2.93 on Friday. Lipella Pharmaceuticals has a 52-week low of $2.21 and a 52-week high of $12.00. The business’s 50 day moving average price is $3.16 and its two-hundred day moving average price is $3.17. The firm has a market cap of $3.54 million, a PE ratio of -0.69 and a beta of 0.28.

Lipella Pharmaceuticals Company Profile

Lipella Pharmaceuticals Inc, a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).